He QH et al. |
[The role of superantigen SEB-induced immunotolerance in the immune privileged site]. |
2003 |
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi |
pmid:15132898
|
Pan ZX et al. |
[IL-18 expression in whole blood cell cultures from active lupus nephritis and the inhibitory effects of FK506, cyclosporin A and dexamethasone]. |
2004 |
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi |
pmid:15555450
|
Kagaya H et al. |
Quantification and 24-hour monitoring of mycophenolic acid by high-performance liquid chromatography in Japanese renal transplant recipients. |
2006 |
Yakugaku Zasshi |
pmid:17139160
|
Naito T |
[Optimal immunosuppressive therapy based on pharmacokinetics and pharmacodynamics of antimetabolites in clinical practice]. |
2010 |
Yakugaku Zasshi |
pmid:21139397
|
Yamaguchi K et al. |
[Case of encephalopathy seemingly caused by tacrolimus at blood concentration near the upper limit of therapeutic range]. |
2012 |
Yakugaku Zasshi |
pmid:22790031
|
Sood S and Muthuraman A |
Activity of tacrolimus: an immunosuppressant, in pyloric ligation-induced peptic ulcer in the rat. |
2009 |
Yakugaku Zasshi |
pmid:19952532
|
Tanaka H et al. |
[Discovery and development of a novel immunosuppressant, tacrolimus hydrate]. |
1997 |
Yakugaku Zasshi |
pmid:9306728
|
Muraki Y |
[Factors affecting the pharmacokinetics after living donor liver transplant]. |
2012 |
Yakugaku Zasshi |
pmid:23023417
|
Uchida K et al. |
Pharmacokinetics of orally administered tacrolimus in lupus nephritis patients. |
2010 |
Yakugaku Zasshi |
pmid:20046074
|
Tanaka Y et al. |
[Effect of tacrolimus on the pharmacokinetics and glucuronidation of SN-38, an active metabolite of irinotecan]. |
2013 |
Yakugaku Zasshi |
pmid:23328499
|